![]() |
市場調查報告書
商品編碼
1454071
防過時藥品標籤市場至2030年的預測:按標籤類型、印刷類型、材料、技術、應用、最終用戶和地區的全球分析Future Proof Pharma Labels Market Forecasts to 2030 - Global Analysis By Labeling Type, Printing Type, Material, Technology, Application, End User and By Geography |
根據 Stratistics MRC 的資料,防過時藥品標籤的全球市場在預測期內將以 17.1%的年複合成長率成長。
防過時的藥品標籤是目的是承受未來法規變化、技術進步和不斷發展的行業標準的藥品標籤。這些標籤目的是維持長期的合規性和有效性,並準確地向醫療保健專業人員和患者傳達重要訊息,例如藥物的劑量和給藥、警告和有效期。
據世界衛生組織(WHO)表示,假冒產品每年給製藥業造成 750 億美元的損失。
更加關注病患安全
該市場防過時策略越來越注重改善標籤設計和資訊清晰度,以減少用藥錯誤並改善患者治療結果。重點包括方便用戶使用的說明、清晰的用法和劑量資訊以及有關潛在風險的明確警告。此外,還整合了用於獲取詳細藥物資訊的2D碼等技術進步,以進一步增強安全措施。
整合複雜度
由於需要高效的防偽解決方案、遵守嚴格的法規以及引進 RFID 技術來監控藥品的品質和流動,製藥業的市場整合包括多種複雜性。此外,在某些地區,分銷過程是手動管理的,因此難以管理適當的庫存和有效期。這種複雜性凸顯了實施和管理防過時藥品標籤的挑戰,特別是在流通結構和手動流程複雜的地區。
正確藥物資訊的需求日益成長
由於法規強化、對病人安全的關注和技術進步,市場對正確藥物資訊的需求日益成長。追蹤技術和智慧標籤的整合增強了供應鏈的可視性和以患者為中心的標籤解決方案。此外,數位印刷技術的採用徹底改變市場,使製藥公司能夠創建耐用、防篡改且包含動態資料的標籤。
認知有限
這主要是由於標籤法規和技術的複雜性和不斷發展的性質。許多製藥公司,尤其是小型製藥公司,可能沒有完全了解防過時解決方案的好處和要求。資源和專業知識有限的小型製藥公司可能對防過時解決方案的好處和要求了解不足。此外,全球監管環境的多樣化進一步使意識工作變得更加複雜。
COVID-19 大流行防過時的藥品標籤市場產生了重大影響,促使人們更加關注安全性、可追溯性和監管合規性。隨著製藥業面臨前所未有的挑戰,對確保產品真實性、防篡改以及追蹤疫苗分銷和打擊假藥的連續性的標籤的需求不斷成長。此外,疫情也加速了2D碼和RFID技術等數位解決方案的採用,使供應鏈更具彈性並實現遠端監控。
感壓標籤市場預計將在預測期內成為最大的市場
預計感壓標籤市場在預測期內將是最大的市場。由於材料科學和印刷技術的進步,感壓標籤已準備好滿足不斷變化的行業需求,包括序列化和防偽措施。它易於使用且能夠黏附在各種表面上,使其成為藥品包裝的最愛,可提高效率並在整個供應鏈中實現準確的產品識別和追蹤。
預計彈性凸版印刷產業在預測期內的年複合成長率最高
預計彈性凸版印刷產業在預測期內的年複合成長率最高。隨著可追溯性、安全性和法規遵循的要求不斷提高,彈性凸版印刷提供了能夠承受惡劣環境條件的高品質、耐用標籤。此外,彈性凸版印刷技術的進步,例如改進的油墨配方和基材相容性,可確保藥品標籤符合不斷發展的行業標準。
由於採用智慧標籤和防篡改功能等創新標籤解決方案,預計北美在預測期內將佔據最大的市場佔有率。此外,對個人化醫療和追蹤功能不斷成長的需求進一步推動了市場擴張。由於強調提高整個供應鏈的效率和安全性,藥品標籤市場預計在未來幾年將持續成長和發展。
預計亞太地區在預測期內將維持最高的年複合成長率。由於人口成長、醫療保健意識增強和收入水準提高等因素,該地區的藥品消費日益增加。藥品消費的增加直接推動了對藥品標籤的需求。製藥業越來越關注病人安全,導致對有助於準確劑量和給藥說明的標籤的需求增加。
According to Stratistics MRC, the Global Future Proof Pharma Labels Market is growing at a CAGR of 17.1% during the forecast period. Future Proof Pharma Labels is pharmaceutical labels designed to withstand future regulatory changes, technological advancements, and evolving industry standards. These labels are intended to remain compliant and effective over time, ensuring that important information such as drug dosage, administration instructions, warnings, and expiration dates are accurately conveyed to healthcare professionals and patients.
According to the World Health Organization, globally, counterfeiting costs the pharma industry USD 75 billion every year.
Growing emphasis on patient safety
Future-proofing strategies in this market increasingly focus on enhancing label designs and information clarity to reduce medication errors and improve patient outcomes. Emphasis is placed on incorporating user-friendly instructions, clear dosage information, and prominent warnings about potential risks. Additionally, advancements in technology, such as QR codes for accessing detailed medication information, are being integrated to further enhance safety measures.
Complexity of integration
The integration of market in the pharmaceutical industry presents several complexities due to the need for efficient anti-counterfeiting solutions, adherence to stringent regulations, and the deployment of RFID technology for monitoring drug quality and movement. Additionally, the distribution process in certain regions is managed manually, leading to difficulties in managing proper inventory and expiry dates. These complexities highlight the challenges in implementing and managing future-proof pharma labels, especially in regions with complex distribution structures and manual processes
Rising need for accurate medication information
The market is witnessing a rising need for accurate medication information driven by increasing regulations, patient safety focus, and technological advancements. The integration of track-and-trace technologies and smart labels is enhancing supply chain visibility and patient-centric labeling solutions. Furthermore, the adoption of digital printing technologies is revolutionizing the market, allowing pharmaceutical companies to produce durable, tamper-evident labels with dynamic data.
Limited awareness
Limited awareness persists in the market, primarily due to the complex and evolving nature of labeling regulations and technologies. Many pharmaceutical companies, especially smaller ones, may not be fully informed about the benefits and requirements of future-proof labeling solutions. Smaller pharmaceutical companies may not be fully informed about the benefits and requirements of future-proof labeling solutions due to limited resources and expertise. Moreover, the diverse global regulatory landscape further complicates awareness efforts.
The COVID-19 pandemic has significantly impacted the Future Proof Pharma Labels Market, prompting a heightened focus on safety, traceability, and regulatory compliance. With the pharmaceutical industry facing unprecedented challenges, there's a growing demand for labels that ensure product authenticity, tamper-evidence, and serialization to track vaccine distribution and combat counterfeit drugs. Moreover, the pandemic has accelerated the adoption of digital solutions, such as QR codes and RFID technology, enhancing supply chain resilience and enabling remote monitoring.
The pressure-sensitive labels segment is expected to be the largest during the forecast period
The pressure-sensitive labels segment is expected to be the largest during the forecast period. With advancements in material science and printing technologies, pressure-sensitive labels are poised to meet evolving industry needs, including serialization and anti-counterfeiting measures. Their ease of application and ability to adhere to various surfaces make them a preferred choice for pharmaceutical packaging, enhancing efficiency and ensuring accurate product identification and tracking throughout the supply chain.
The flexographic printing segment is expected to have the highest CAGR during the forecast period
The flexographic printing segment is expected to have the highest CAGR during the forecast period. With increasing demands for traceability, security, and regulatory compliance, flexographic printing offers high-quality, durable labels capable of withstanding stringent environmental conditions. Moreover, advancements in flexographic technology, such as improved ink formulations and substrate compatibility, ensure that pharmaceutical labels meet evolving industry standards.
North America is projected to hold the largest market share during the forecast period due to their adoption of innovative labeling solutions, including smart labels and tamper-evident features. Moreover, rising demand for personalized medicine and track-and-trace capabilities further fuels market expansion. With a focus on enhancing efficiency and safety throughout the supply chain, the pharmaceutical labels market in is expected to experience sustained growth and evolution in the coming years.
Asia Pacific is projected to hold the highest CAGR over the forecast period. The region is witnessing a rise in pharmaceutical consumption due to factors such as population growth, increasing healthcare awareness, and rising income levels. This growth in pharmaceutical consumption directly contributes to the demand for pharmaceutical labels. There is a growing emphasis on patient safety in the pharmaceutical industry, leading to increased demand for labels that facilitate accurate medication administration and dosage instructions.
Key players in the market
Some of the key players in Future Proof Pharma Labels market include Denny Bros Ltd., Loftware, Inc., R.R. Donnelley & Sons Company, 3M Company, CCL Industries Inc., UPM Raflatac, Inc., Essentra PLC, WS Packaging Group, Inc., Schreiner Group GmbH & Co. KG, Covectra, Inc., Avery Dennison Corporation, Taylor Communications, Zebra Technologies, Honeywell, Graphic Label, Inc., DuPont and Sato Corporation.
In July 2023, CCL Industries Inc., has announced the acquisition of Faubel & Co. Nachfolger GmbH ("Faubel"), a specialist in labels for pharmaceutical clinical trials. The acquisition marks a strategic move by CCL Industries to build a stronger global presence in the healthcare sector and positions the company as a key player in clinical trials labeling.
In March 2023, 3M announced a collaboration with Guardhat, an industry-leading connected safety software company. Given the importance of connectivity as a key ingredient in safety programs, 3M is transferring its Safety Inspection Management (SIM) software to Guardhat.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.